Is PRRT Right For You?
How do doctors determine that PRRT should be the treatment of choice for a neuroendocrine tumour? PRRT or Peptide Receptor Radionuclide Therapy is a molecular therapy that is one of the accepted modes of treatment for Neuroendocrine Tumours (NETs). Before we go on to discuss the above topic at hand, let me explain PRRT. In PRRT, a radiopeptide is created by combining a small amount of radioactive material or radionuclide (Yttrium-90 or Y-90 and Lutetium-177 or Lu-77) with a cell-targeting protein. This radiopeptide, when injected into a neuroendocrine tumour patient’s bloodstream, travels and binds itself to the neuroendocrine tumour cells to deliver a high dose of radiation that targets only the cancer cells. Also Read: How Does a Typical PRRT Day look like? Doctors recommend PRRT for patients diagnosed with Advanced Metastatic or Progressive Neuroendocrine Tumours (NETs); also for NET patients who are ineligible for surgery; and also for those NET patients who are unrespo